KRAS mutation in metastatic pancreatic ductal adenocarcinoma: Results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy

1 Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial Annals of Oncology, May 20, 2013

2 Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis Nutrition Reviews, April 30, 2013    Evidence Based Medicine    Review Article

3 Cigarette smoking and the risk of barrett's esophagus: a systematic review and meta-analysis Journal of Gastroenterology and Hepatology, April 29, 2013    Evidence Based Medicine    Review Article

4 Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation European Journal of Cancer, April 25, 2013

5 Contemporary grading for prostate cancer: implications for patient care European Urology, May 8, 2013

6 A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer British Journal of Cancer, May 23, 2013

7 Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barretts Esophagus: A Systematic Review and Meta-analysis Clinical Gastroenterology and Hepatology , May 21, 2013

8 Human papillomavirus infection and colorectal cancer risk: a meta-analysis Colorectal Disease, May 3, 2013

9 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, May 3, 2013

10 A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma World Journal of Surgical Oncology, May 1, 2013